News & Blog

Brain Tumor Research Highlights: August 2017

To see July’s Brain Tumor Research Highlights, click here. Over the years, NBTS has given more than $35 million to brain tumor research projects. We’re very proud of the impact this funding has made in advancing the neuro-oncology field closer to better treatments and ultimately a cure. And while NBTS is currently focused on driving our flagship […]

Brain Tumor Research Highlights: July 2017

Note: In June, our 2017 Defeat GBM Research Collaborative Progress Report replaced our regular, standard monthly “Brain Tumor Research Highlights” blog. To see April’s Brain Tumor Research Highlights, click here. Over the years, NBTS has given more than $35 million to brain tumor research projects. We’re very proud of the impact this funding has made in advancing […]

Potential Glioblastoma Treatments Entering The Pivotal Phase of Evaluation

Jump Ahead to List of Trials Glioblastoma (GBM) is the most common and aggressive malignant brain tumor and, regrettably, very limited treatment options exist for these patients. The current standard-of-care for newly diagnosed patients is surgery, followed by radiation and chemotherapy (with temozolomide), and, in some cases, use of the tumor-treating-field device, Optune. If and […]

Share